Intelligence · Clinical Pipeline
First Biotech (Australia) Pipeline
All ClinicalTrials.gov programs at First Biotech (Australia) — phase, modality, and trial IDs.
- Programs
- 7
Quick answer
First Biotech (Australia) has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)
Pfizer Australia Pty Ltd
RSV-infection
1 trial -
Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar sus
Pfizer Australia Pty Ltd
VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIA
1 trial -
Braftovi 50 mg hard capsules, Zelboraf 240 mg film-coated tablets, Encorafenib, Erbitux 5 mg/mL solution for infusion, PEMBROLIZUMAB, Braftovi 75 mg hard capsules, Braftovi 75 mg hard capsules, Braftovi 50 mg hard capsules, Ribociclib, Ribociclib, NIVOLUMAB, Mektovi 15 mg film-coated tablets, Mektovi 15 mg film-coated tablets, Ribociclib
Pfizer Australia Pty Ltd
Solid tumors
1 trial -
LORLATINIB
Pfizer Australia Pty Ltd
Lung cancer
1 trial -
Placebo for Rimegepant 75 mg, VYDURA 75 mg oral lyophilisate
Pfizer Australia Pty Ltd
migraine headaches with or without aura
1 trial -
VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg
Pfizer Australia Pty Ltd
Migraine attacks with or without aura
1 trial -
XALKORI 200 mg hard capsules, XALKORI 250 mg hard capsules, Crizotinib 200 mg capsules, Crizotinib 250 mg capsules
Pfizer Australia Pty Ltd
This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed
1 trial
Frequently asked questions
How many pipeline programs does First Biotech (Australia) have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs